Bio-Techne (TECH) President William Geist Receives Award

What Happened

• William Geist, President, Protein Sciences at Bio-Techne (TECH), received two awards of restricted stock units (RSUs) on 2026-08-17. The grants total 38,747 RSUs: 14,762 RSUs and 23,985 RSUs, each reported with an acquisition price of $0 (award/derivative grant). These are compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-08-17; Form 4 filed 2026-08-19 (timely filing within the reporting window).
• Awards: 14,762 RSUs (footnote F10) and 23,985 RSUs (footnote F11); total = 38,747 RSUs; acquisition price reported $0 (code A = award).
• Vesting (per footnotes):
  • 14,762 RSUs: 4,921 RSUs vest on 8/17/2027, 4,921 on 8/17/2028, and 4,920 on 8/17/2029 (F10).
  • 23,985 RSUs: vest on 8/17/2029 (F11).
  • Each RSU represents a contingent right to one share of common stock (F5).
• Footnote F1 indicates some awards/options elsewhere are 100% vested; the two grants above follow the multi-year schedules noted (F10, F11).
• Shares owned after the transaction: not specified in the provided excerpt—see the full Form 4 for total holdings.

Context

• These are derivative compensation awards (RSUs). RSUs convert into actual shares only when they vest (per the schedules above); they are not immediate cash or open-market purchases/sales.
• Such awards are typically part of executive compensation and are not direct market-timing signals. They align incentives over the vesting period but do not by themselves indicate buying or selling sentiment.